![]() Micrococcal nuclease structure
|
Common Name | Micrococcal nuclease | ||
---|---|---|---|---|
CAS Number | 9013-53-0 | Molecular Weight | 295.29 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C26H22N4O7S2 | Melting Point | N/A | |
MSDS | USA | Flash Point | N/A |
Use of Micrococcal nucleaseMicrococcal nuclease is a biochemical reagent that can be used as a biological material or organic compound for life science related research. |
Name | N,N'-[(4-Oxo-3-naphthalenyl-1-ylidene)bis(sulfamoyl-4,1-phenylene)]diacetamide |
---|---|
Synonym | More Synonyms |
Description | Micrococcal nuclease is a biochemical reagent that can be used as a biological material or organic compound for life science related research. |
---|---|
Related Catalog |
Molecular Formula | C26H22N4O7S2 |
---|---|
Molecular Weight | 295.29 |
Storage condition | 2-8°C |
Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
---|---|
RIDADR | NONH for all modes of transport |
Mutant p53 cooperates with the SWI/SNF chromatin remodeling complex to regulate VEGFR2 in breast cancer cells.
Genes Dev. 29 , 1298-315, (2015) Mutant p53 impacts the expression of numerous genes at the level of transcription to mediate oncogenesis. We identified vascular endothelial growth factor receptor 2 (VEGFR2), the primary functional V... |
|
E2F1-mediated FOS induction in arsenic trioxide-induced cellular transformation: effects of global H3K9 hypoacetylation and promoter-specific hyperacetylation in vitro.
Environ. Health Perspect. 123 , 484-92, (2015) Aberrant histone acetylation has been observed in carcinogenesis and cellular transformation associated with arsenic exposure; however, the molecular mechanisms and cellular outcomes of such changes a... |
|
Genome-wide in vitro reconstitution of yeast chromatin with in vivo-like nucleosome positioning.
Meth. Enzymol. 513 , 205-32, (2012) Recent genome-wide mapping of nucleosome positions revealed that well-positioned nucleosomes are pervasive across eukaryotic genomes, especially in important regulatory regions such as promoters or or... |
Acetamide, N-[4-[[[(1Z)-3-[[[4-(acetylamino)phenyl]sulfonyl]amino]-4-oxo-1(4H)-naphthalenylidene]amino]sulfonyl]phenyl]- |
MFCD00131731 |
N,N'-[(4-Oxo-3-naphthalenyl-1-ylidene)bis(sulfamoyl-4,1-phenylene)]diacetamide |